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Abstract 
 Screening of oncologic pathology of gastro-intestinal tract  by means of multicenter 
endoscopic examination has shown that phylactic esophagogastroduodenoscopy, 
сolonofiberscopy  can be recommended as an obligatory component during planned 
examination. 
 
Keywords: Screening, endoscopy, oncology 
 
Relevance 
 Despite all the achievements of modern medicine , the entry of new methods of 
diagnosis and healing, the disease incidence and death rate due to oncologic diseases has 
been constantly increasing in the world. It is well-known , that cancer is the second leading 
reason of death after cardiovascular system diseases death.  
 If to summarize the cancer frequency of all organs of gastro-intestinal tract, it will 
take the first place (more than 50%), powering past larynx cancer, breast cancer, and prostate 
cancer
1.
 Therewith disease and death rate are the cancer of approximately all digestive 
systems 
2
. 
 Numerous research proves, that disease prognosis mainly depends on oncology 
diagnose promptness, which gives much meaning to the earlier diagnosis. Unfortunately, 60–
80% patients with for the first time oncology diagnose already have III–IV stages of disease2.  
Potential causes of such late diagnose are late application of patients, erased clinical 
performance, and also deficient oncological suspicion of doctors with primary stage of 
healthcare.  
 In recent times in all well-developed countries fast disease growth of segmented 
intestine cancer is noticed 
3.
 Approximately  85% cases of colorectal cancer (CRC)are on the 
age older than 55.  CRC is of rare occurrence with people under the age of 30 ,  the disease 
sharply rises with the age increase, reaching the maximum after 70 years old. The disease rate 
of colorectal cancer in industrially developed countries comparing with developing is 
significantly higher. Its early diagnose usually is possible on preclinical stage, which requires 
special laboratory-instrumental screening survey.  
 Nowadays in the USA and well-developed Western countries the screening programs 
are intruded, based on identification of implicate blood in  fecal matter, however they are not 
specified enough, and the amount of false-negative results are quite large and equal to from 
30 to 70%
 4
. For screening  diagnosis of colorectal cancer , digital investigation has not lost 
its significance. However, despite the accessibility of the method, the great amount of 
oncology still are identified on incurable stages
5. 
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 Endoscopic research is still a «Golden Standard» of diagnosis. The analysis of 
literature resources shows the efficiency of multicenter endoscopic investigation, which is 
one of the most leading methods on the finishing stage of examination for patients to identify 
oncological pathology
[6.
 
 The high level of informative value, simplicity and respective safety of endoscopic 
methods let use them in stationery conditions as well as in ambulatory conditions to resolve 
issues of cancer disease diagnosis, and also supervision of people, related to the groups of 
high risk of cancer
7
 
 We have done the analysis of screening diagnosis of oncological pathology of gastro-
intestinal tract by means of multicenter endoscopic survey.  
 
Research material and methods 
 The materials of the analysis were results of investigation of endoscopic survey, 
carried out in regional hospital named G. Sultanov , period from 2008 to 2011. The diagnose 
varied on the basis of morphologic investigations and endoscopic picture of  gastro- intestinal 
tract's organs. The methods, used are: esophagogastroduodenoscopy (EGD), 
colonofiberscopy, rectosigmoidoscopy (RRS), fiber-optic bronchoscopy The obtained results 
were exposed to statistical analysis. 
 
Results of the research 
 For the period from 2008 to 2011 in regional hospital named G. Sultanov there were 
15067 endoscopic surveys, taken  2699 (17,91%) biopsies, and found out 107 (3,96%) cases 
with oncological pathology, confirmed by morphological investigation. Most of 
investigations are oriented to EGD 89,89% (13543 patients), least  fiber-optic bronchoscopy 
– 2,26% (340 patients) Data is represented in the table 1. 
Table1- Amount of endoscopic investigations from 2008 to 2011 
№ Type of Investigation 
Biopsies Biopsies Oncopathology 
Pat. % Pat. % Pat. % 
1 EGD 13543 89,89 2373 17,52 78 3,29 
2 Colonofiberscopy 588 3,90 305 51,87 15 4,92 
3 RRS 596 3,96 7 1,17 3 42,86 
4 Fiber-optic bronchoscopy 340 2,26 14 4,12 11 78,57 
Total: 15067 2699 17,91 107 3,96 
 
 How it can be seen from the table 1, most of oncologic diseases,  exposed to 
morphological investigations, is noted in fiber-optic bronchoscopy, from 14 biopsies in 
78,57% (11 cases) verified oncopathology. The goes the investigation of straight intestine -  
RRS, from 7 cases- three of them 42,86%)positive. Therewith the amount of carried fiber-
optic bronchoscopies for four is 2,26% (340 patients), and RRS – 3,96% (596 patients) from 
total number of endoscopic investigations. 
 Patients, being examined RGD are 89,89% (13543 people) from them 17,52% (2373 
people) were taken  a biopsy , the results of which  78  (3,29%) people have oncological 
diseases. 
 Colonofiberscopy was carried to 588 (3,90%) patients, from them 51,87% (305 
people) were taken a biopsy and only 15 (4,92%) people have oncopathology. 
 While morphological investigation of biopsy materials , taken during endoscopy, the 
most frequent cancer is a gastric cancer, the results of morphological investigation are shown 
in the table 2. 
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Table 2 - the results of morphological investigation from 2008 to 2011 
№ Nosology 
Men Women Total 
Pat. % Pat. % Pat. % 
1 Esophageal cancer 9 8,4% 6 5,6% 15 14 
2 Gastric cancer 42 39,3% 21 19,6% 63 58,9 
3 Large intestine cancer 9 8,4% 9 8,4% 18 16,8 
4 Others 10 9,3% 1 0,9% 11 10,3 
Total: 70 65,4 37 
34,6 
 
107 
 
 From this table we can see that 107 patients have oncology 65,4% (70 people) men 
and  34,5% (37 people) women. The most frequent verified is gastric cancer– 58,9% (63 
cases), from them 39,3% men, then goes large intestine cancer – 16,8% (18 cases), 
esophageal cancer – 14% (15cases).   
 In other cases, patients have pathologies, related to pre-cancer diseases. Special 
Committee WHO recommends to differentiate pre-cancer conditions and pre-cancer changes. 
To the first ones, are related the diseases, which determine significant increase of cancer risk: 
chronic gastritis, peptic ulcer, polyposis, gastric remnant gastritis. To the second ones- 
structural changes of tissues, in which cancer can appear with higher probability than in a 
normal tissue: intestinal metaplasia and mucous coat of stomach epithelium dysplasia 
8 9 10 11 
12 13 14 15 16 17. 
Recrudescent and long time open forms of peptic ulcer with achlorhydria 
18
, 
callous gastric ulcer, torpid process of ulcerous defect cicatrization
19,20,21,22,23,24,25
 coexist 
atrophic and dysplatic changes 
26,27,28
. Results of endoscopic investigations are represented in 
table 3. 
Table 3 – Amount of pre-cancer diseases within endoscopic investigation from  2008 to 2011 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 This table shows, that the most frequent is chronic gastritis 63,4% (1546 people) cases, 
the second position is gastric erosion– 10,2% (249 people) cases. While investigating large 
intestine , the first place takes chronic colitis– 4,2% (102 people) cases, further go the polyps 
of large intestine– 2,1% (51 people) cases. Gastric ulcer is 5,8% (142 people) cases  
Duodenum ulcer is 2,6% (63 people) cases . Gastric  and duodenum polyps are identified in 
104 (4,3%) patients, duodenitis  are diagnosed in 94 (3,9%) people. In different years there is 
an irregularity of people appealability, peak of an  appealability  is accounted for 2010. 
 Infection Helicobacterpylori (H.Рylori) for today is the most leading factor in the 
gastric cancer pathogenesis. Especially this one is the reason of chronic gastritis development 
– obligatory stage in the chain of procedures, leading to gastric cancer. This process was 
№ Nosology 
Year of investigation Total 
2008г. 2009г. 2010г. 2011г. Pat. % 
1 Esophagitis 16 6 9 7 38 1,6 
2 Barrett esophagus 3 - 2 1 6 0,2 
3 Chronic gastritis 409 223 613 301 1546 63,4 
4 Peptic ulcer 55 31 27 29 142 5,8 
5 Duodenum ulcer 35 4 16 8 63 2,6 
6 Gastric erosion 92 27 42 88 249 10,2 
7 Duodenum erosion 6 6 4 10 26 1,1 
8 Duodenitis 35 8 25 26 94 3,9 
9 Gastric  and duodenum polyps 29 28 24 23 104 4,3 
10 Chronic colitis 23 41 34 4 102 4,2 
11 Nonspecific ulcerative colitis 5 5 1 6 17 0,7 
12 Large intestine polyp 10 25 14 2 51 2,1 
Total: 718 404 811 505 2438 
European Scientific Journal  September 2014  /SPECIAL/ edition Vol.3   ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
203 
named as «Cascade Correa»  –  by the name of the author, who was the first to describe 
development stages of gastric adenocarcinoma 
29
. 
 In 1994 International agency for cancer study included H. pylori  in the list of 
carcinogen. H. Рylori is considered as an incitant of cytolergy nowadays. The risk of  gastric 
cancer development  increases at the patients infected with H. pylori with chronic gastritis in 
2–6 times in comparison with not infected ones.  The expressed interrelation between an 
infection of H. pylori and gastric cancer  is proved in the prospective incidence study
30
.  
 On H. Pylori 1208 patients from them 47,5% (574 people) men and 52,5% (634 
people) women were surveyed. These researches are presented in table 4. 
Table 4 - Results of research on Helicobacter pylori from 2008 for 2011 
№ Age 
H. pylori positive H. pylori negative Total 
Men Women Men Women Pat. % 
1 17-25 years 49 39 28 31 147 12,2 
2 26-50  years 150 171 116 117 554 45,9 
3 51 and older 123 133 108 143 507 42,0 
Total: 
322 
26,7% 
343 
28,4% 
252 
20,9% 
291 
24,1% 
1208 
665 
55% 
543 
45% 
 
 As we can see from table 4 that results on H. Pylori in 55% (665 patients) cases 
positive with prevalence of female persons – 28,4% (343 persons), generally in category of 
patients from 26 to 50 years - 26,6% (321 persons) cases. 
 
Conclusion 
 Thus, the analysis of screening diagnostics of oncologic pathology of a 
gastrointestinal tract by complex endoscopic research showed that preventive EDG, 
Colonofiberscopy can be recommended as an obligatory component at planned inspection of 
patients. So as a result of the conducted research at EGD the carcinoma of the stomach at 
58,9% (63 cases), an esophagus cancer at 14% (15 cases), identified 55 by % (665 patients) 
positive cases on H.Pylori was verified, at 2268 people precancerous diseases (esophagites, 
chronic gastritis, stomach erosions, a peptic ulcer of a stomach and a duodenum, polyps of a 
stomach, duodenum) are taped. At Colonofiberscopy the cancer of a colon is diagnosed for 
16,8% (18 cases), a chronic colitis, colon polyps, the nonspecific ulcerative colitis relating to 
pre-cancerous diseases are found in 170 patients.  
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